08045804946
medisus.pharma007@gmail.com
भाषा बदलें
Cabazitaxel Injection

Cabazitaxel Injection

उत्पाद विवरण:

  • संकेत Metastatic castration-resistant prostate cancer (mCRPC) previously treated with a docetaxel-containing regimen
  • खुराक प्रपत्र Injection
  • नमक की संरचना Cabazitaxel
  • फ़ीचर
  • सामग्रियां
  • एप्लीकेशन
  • भौतिक रंग/बनावट
  • अधिक देखने के लिए क्लिक करें
X

मूल्य और मात्रा

  • 5

उत्पाद की विशेषताएं

  • 24 months
  • Metastatic castration-resistant prostate cancer (mCRPC) previously treated with a docetaxel-containing regimen
  • Injection
  • Cabazitaxel
  • Store in a refrigerator (2°C - 8°C). Do not freeze. Protect from light.

व्यापार सूचना

  • ,
  • प्रति सप्ताह
  • दिन
  • , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

उत्पाद वर्णन

Kabanat Injection belongs to the general group of medicines called antineoplastics. It is used for thetreatment of advanced prostate cancer. It works by interfering with the growth of cancer cells, which are eventually destroyed.


  1. What is Cabazitaxel?Cabazitaxel is a chemotherapy medication used in the treatment of certain types of cancer, particularly advanced prostate cancer.

  2. What conditions does Cabazitaxel treat?Cabazitaxel is primarily used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) that has progressed despite treatment with other medications, such as docetaxel.

  3. How is Cabazitaxel administered?Cabazitaxel is administered intravenously (into a vein) by a healthcare professional in a clinic or hospital setting. The dosage and frequency of administration will be determined by the patient's specific condition and medical history.

  4. What are the common side effects of Cabazitaxel?Common side effects of Cabazitaxel may include neutropenia (low white blood cell count), anemia (low red blood cell count), thrombocytopenia (low platelet count), nausea, vomiting, diarrhea, fatigue, weakness, and peripheral neuropathy (nerve damage). It's important to report any side effects to your healthcare provider.

  5. Who should not take Cabazitaxel?Cabazitaxel may not be suitable for everyone. Patients with certain medical conditions, such as severe liver impairment or a history of severe allergic reactions to medications containing polysorbate 80, may not be able to take Cabazitaxel safely. It's crucial to inform your healthcare provider about your medical history and any medications you are currently taking before starting Cabazitaxel.

  6. Is Cabazitaxel safe during pregnancy and breastfeeding?Cabazitaxel may cause harm to a developing fetus and is not recommended for use during pregnancy. It is also not known whether Cabazitaxel passes into breast milk, so breastfeeding is typically not recommended while receiving treatment with Cabazitaxel. It's essential to discuss the risks and benefits with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.

  7. Are there any interactions with other medications?Cabazitaxel may interact with other medications, including certain medications used to treat infections and medications that affect liver function. It's crucial to inform your healthcare provider about all medications you are taking, including prescription drugs, over-the-counter medications, vitamins, and supplements, to avoid potential interactions.

 



Key Features and Composition

Cabazitaxel Injection contains Cabazitaxel as its active ingredient, available in a 60 mg/1.5 ml vial with a included solvent for reconstitution. The formulation is designed for IV administration and is intended for single use under prescription-only protocols. The solution appears clear to slightly yellow and is sterile to guarantee patient safety during oncology treatments.


Intended Treatment Use

This injection is primarily indicated for metastatic castration-resistant prostate cancer (mCRPC) in patients who have previously undergone treatment with a docetaxel-containing therapy. Its formulation and administration route are tailored to maximize efficacy for this advanced cancer indication under medical supervision.


Safe Handling and Storage

To maintain product potency and safety, the vials should be stored in a refrigerator at 2C-8C, protected from light, and must not be frozen. The injection comes with a shelf life of 24 months, and only trained healthcare professionals should handle the reconstitution and administration process.

FAQ's of Cabazitaxel Injection:


Q: How should Cabazitaxel Injection be administered?

A: Cabazitaxel Injection is administered intravenously as an infusion by qualified healthcare professionals, typically in a hospital, clinic, or oncology center. The medication is first reconstituted with the provided solvent, then further diluted before being given directly into the bloodstream.

Q: What is Cabazitaxel Injection used for?

A: This medication is prescribed for metastatic castration-resistant prostate cancer (mCRPC) in men who have been previously treated with a docetaxel-containing chemotherapy regimen. It helps slow the progression of advanced prostate cancer.

Q: When is Cabazitaxel Injection typically prescribed?

A: Cabazitaxel Injection is generally prescribed after a patient with prostate cancer no longer responds to hormonal therapies and has already received previous treatment with docetaxel.

Q: Where should Cabazitaxel Injection be stored?

A: The injection vials must be kept in a refrigerator at temperatures between 2C and 8C. They should be protected from light and must never be frozen to preserve their effectiveness.

Q: What is the process for preparing Cabazitaxel Injection for use?

A: A healthcare professional will reconstitute the Cabazitaxel vial with the provided solvent, then dilute the solution further for safe IV infusion. This preparation must be done in a sterile environment to maintain safety and efficacy.

Q: Who is qualified to use and administer this medication?

A: Only licensed and trained healthcare providers are permitted to handle, prepare, and administer Cabazitaxel Injection. The drug is strictly for use in medical facilities such as hospitals, clinics, and oncology centers.

Q: What are the benefits of using Cabazitaxel Injection in mCRPC?

A: Cabazitaxel Injection offers potential benefits for patients with advanced prostate cancer whose disease has progressed despite previous treatment. It may help manage cancer symptoms, potentially improve survival, and enhance quality of life when used as directed by oncologists.

Tell us about your requirement
product

Price:  

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
मोबाइल number

Email

बेवाकिज़ुमैब इंजेक्शन अन्य उत्पाद



Back to top